# FDA Inspection 1148014 - Brigham And Women's Hospital - July 21, 2021

Source: https://www.keypedia.com/records/fda_inspections/brigham-and-womens-hospital/3cbf8d64-1bdc-4b45-8dcd-a843674f5ae0
Source feed: FDA_Inspections

> FDA Inspection 1148014 for Brigham And Women's Hospital on July 21, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1148014
- Company Name: Brigham And Women's Hospital
- Inspection Date: 2021-07-21
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1244354 - 2024-06-12](https://www.keypedia.com/records/fda_inspections/brigham-and-womens-hospital/ec0aaeab-f1a2-48d2-a892-7c4ac866d4ae)
- [FDA Inspection 1148014 - 2021-07-21](https://www.keypedia.com/records/fda_inspections/brigham-and-womens-hospital/46c4f996-ca8f-40da-8510-c9c31bd5806d)
- [FDA Inspection 1103194 - 2019-09-26](https://www.keypedia.com/records/fda_inspections/brigham-and-womens-hospital/b5b4f959-1f3b-4db5-a524-56ca27f9e3ac)
- [FDA Inspection 1103194 - 2019-09-26](https://www.keypedia.com/records/fda_inspections/brigham-and-womens-hospital/1c37619f-3516-433b-8903-a60f55909ef0)
- [FDA Inspection 1019087 - 2017-06-23](https://www.keypedia.com/records/fda_inspections/brigham-and-womens-hospital/ae624f11-3455-4892-ba78-09cb36b4be03)

Company: https://www.keypedia.com/companies/brigham-and-womens-hospital/bd1bc676-ff7b-48b7-b9a2-3db7aaf9732d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d